Peer-led Trauma Therapy for Re-entry
Status
Conditions
Treatments
Study type
Funder types
Identifiers
Details and patient eligibility
About
The purpose of the research is to learn more about how to treat PTSD for people directly impacted by incarceration (i.e., have spent time in prison or jail). This research will help identify if a PTSD treatment group that is used in community settings, and led by individuals with lived experience, is helpful in reducing PTSD symptoms among people who have been directly impacted by incarceration.
Participants will complete an interview to determine whether they are experiencing PTSD, and if so, will participate in a 6-week therapy group treatment.
Full description
Two community Certified Peer Specialists (CPSs) who have experienced incarceration and re-entry from prison, and who have experienced trauma will be trained on delivering group Cognitive Processing Therapy (CPT).
Working with the Wisconsin Department of Health Services (DHS) and community organizations serving formerly incarcerated individuals, researchers will screen individuals for PTSD treatment need, and invite 48 eligible individuals to participate in group CPT co-led by one of the trained CPSs and a trained community therapist or provider.
Eligible participants who are enrolled in the study will be invited to complete a 6-week (12 sessions total) group CPT therapy treatment for PTSD. Participants will also complete pre-, mid-, and post-treatment mental health surveys. Participants will also complete a post-treatment focus group or post-treatment individual interview where they are asked about their experience in the therapy and to provide feedback on the study as a whole.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- 18 years of age or older
- completed a prison or jail sentence
- no current psychosis symptoms
- no active self-harm or active suicidal intent
- able and willing to participate in group therapy
- meet criteria for PTSD treatment need
Exclusion criteria
- current and active psychosis
- current and active self-harm and suicidality
- no PTSD diagnosis
- current substance use dependence (not including those used as prescribed for medical reasons) on alcohol, cocaine, amphetamines, inhalants, sedatives or sleeping pills, hallucinogens, or opioids
Trial design
Primary purpose
Allocation
Interventional model
Masking
59 participants in 1 patient group
Trial contacts and locations
Loading...
Central trial contact
Michael Koenigs, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal